StockData
Aspire-Lakewood Holdings, Inc. logo

Aspire-Lakewood Holdings, Inc. (ASBP) stock

ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 2/30
$7.89−0.41 (-4.94%)

Close on Nov 18, 2026Market cap $11.07MP/E –Yield –

Aspire-Lakewood operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Aspire-Lakewood's operating income for the twelve months ending Jun 30, 2026 was -$7.32M. For fiscal 2025 it was -$19.35M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$19.35M–
FY2024Dec 31, 2024-$1.21M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.68M–
Q1 FY2026Mar 31, 2026-$1.65M–
Q4 FY2025Dec 31, 2025-$1.85M–
Q3 FY2025Sep 30, 2025-$1.15M–
Q2 FY2025Jun 30, 2025-$799.89K–
Q1 FY2025Mar 31, 2025-$15.56M–
Q4 FY2024Dec 31, 2024-$667.72K–
Q3 FY2024Sep 30, 2024-$215.26K–

More Aspire-Lakewood figures

See a number that looks wrong?